We studied patients with sickle cell disease, which is considered a prototype for purely ischaemic retinopathy. A recent investigation showed that the BRB was normal in sickle cell patients with background retinopathy as measured by fluorescein leakage on vitreous fluorophotometry; leakage was evident only when peripheral neovascularisation was also present.
Retinal vascular disease has two major pathophysiological processes: alteration of the blood-retinal barrier (BRB), as reflected by capillary leakage, and ischaemia, as Visual field testing has been used to measure functional damage from retinal disease in diabetes and branch vein occlusions7 "in an attempt to correlate dysfunction with the amount ofdamage from capillary non-perfusion.
We studied patients with sickle cell disease, which is considered a prototype for purely ischaemic retinopathy. A recent investigation showed that the BRB was normal in sickle cell patients with background retinopathy as measured by fluorescein leakage on vitreous fluorophotometry; leakage was evident only when peripheral neovascularisation was also present.
Corrcspondcncc to Morton F Goldbcrg, MD. 1855 W Taylor Strcet, Chicago. IL 60612, USA. We applied both fluorescein angiography and visual field perimetry to quantify vascular closure and retinal tissue function in sickle cell patients with and without observable maculopathy and in normal controls.
Materials and methods

PATIENTS
We reviewed the medical records of 186 consecutive patients being followed up in the Sickle Cell Eye Center and recruited those patients with ophthalmoscopic evidence of the macular depression sign"' or angiographic evidence of arteriolar occlusion in the macular. Eyes that had undergone prior laser photocoagulation, cryotherapy, or intraocular surgery were excluded. All patients had electrophoretic confirmation of SS, SC, SA or S-thalassaemia haemoglobin. Patients with a visual acuity worse than 20/50, cloudy media (that is, cataract, vitreous debris), glaucoma, unrelated retinal disease such as diabetes or sarcoidosis, or an unrelated cause for a visual field defect were excluded. Of 40 patients who had macular disease as defined above, 10 (group A) met our criteria for this study. The test eye had the more severe retinopathy of the two eyes. 540 Table 5 Visualfield defects in sickling maculopathy years). Four patients were male and six were female; all had a visual acuity equivalent to or better than 20/30 (see Table 1 ). Group B contained eyes without maculopathy that underwent angiography. The patients ranged from 14 to 58 years in age (mean 35-6 years). Three patients were male and seven were female. Only one had a visual acuity of 20/50; the remaining nine had visual acuities equivalent to or better than 20/30 (see Table 2 ).
Group C was composed of eyes without maculopathy that underwent perimetry. The patients were from 14 to 46 years of age (mean 30 2 years). Five patients were male and five were female. Only one had a visual acuity of 20/50; the other nine had visual acuities equivalent to or better than 20/30 (see Table 3 ).
All normal controls were in their twenties; four were female and two were male. And none had evidence of ophthalmic or systemic disease at their ophthalmic examination. The average of the longest diameter of the FAZ measured in group A was 0*81, SD 0-27 mm (range 0-43 to 1-42 mm; see Table 1 ), as compared with 0-68, SD 0-17 mm (range 0*43 to 0.86 mm) in group B (see Table 2 ). The difference between the normal controls and the patients with maculopathy (group A) was statistically significant (p=0-016, Wilcoxon rank sum test; see Table 4 ). The difference was not statistically significant between the two subsets of sickle cell patients or between the normal controls and the patients without maculopathy, though the latter comparison approached significance (p=006, Wilcoxon rank sum test).
VISUAL FIELDS
All five values, (1) the largest scotoma, (2) average sensitivity depression of the largest scotoma, (3) total number of defects, (4) average sensitivity depression of point 3, and (5) total field sensitivity depression, were significantly larger in group A than in group C ( have correlated the size of the FAZ with the severity of capillary non-perfusion in the posterior pole; the median longest diameter was 0*80 mm in their normal controls and 0-92 mm in their diabetic patients. Conversely, Bird and Weale'6have found an avascular zone of only 0-20 mm in six subjects who visualised their retinal vasculature entoptically. The authors thought that crossing capillaries, which are often undetected by standard angiography, could be seen entoptically.
Vaso-occlusion is the precipitating event in the development of ischaemia in sickle cell retinopathy. Although the retinopathy of the sickle cell haemoglobinopathies is most frequently described in the peripheral retina, macular disease occurs in approximately 20% of cases."" 8 The macular area is predisposed to vascular occlusion because end arterioles terminate along the horizontal raphe around the FAZ.
The significance of the FAZ with respect to visual function has been studied in relation to diabetes'4 120 (Smith RT, et al., paper in preparation). All but one of our subjects who underwent angiography had excellent visual acuity, and all of the patients with maculopathy had visual acuities equivalent to or better than 20/30. None had any related visual complaints, yet their FAZ was in general uneven and displayed prominent irregularities. When compared with that of the normal controls the FAZ enlargement of the maculopathy group was statistically significant. A clear demonstration of statistical significance between those patients with and without maculopathy, however, may require a larger sample size.
Technically, the use of a saline flush after fluorescein injection provided us with much clearer and crisper views of the FAZ than could be obtained by the standard technique. The reproducibility of our technique was evidenced by the ability to superimpose over the initial angiograms the follow-up angiograms at six months in our normal controls. We are confident that measurement of the FAZ with angiography is an accurate and reliable method.
We had difficulty, however, in delineating the FAZ in four of the angiograms, in which crossing vessels through larger areas of non-perfusion were seen. We considered these crossing vessels to be part of the outline of the FAZ. We may therefore have underestimated the real dimensions of the FAZ, particularly in those patients with maculopathy.
Octopus perimetry has also been used to establish the presence of non-perfusion in the peripheral retina78 (Charles HC, unpublished data). In one investigation 600 angiography, as compared with Octopus visual fields of the central 300 and peripheral 30°to 600, was performed on 14 eyes with diabetes and 14 eyes with branch vein occlusion.7 Good correlation was observed between regional visual field changes and retinal capillary non-perfusion; prominent areas of field depression and dropout were especially pronounced in the midperiphery in diabetic retinopathy. In another study' areas of non-perfusion on angiography in 163 diabetic eyes correlated well with Octopus visual field defects.
We attempted to quantify the visual field defects in our patients through several manipulations of the threshold depressions via the computerised printout. We calculated the average sensitivity depression of the largest single scotoma and the total number of scotomas to determine an approximate level of threshold sensitivity. A small, very depressed or abnormal scotoma, however, would be less abnormal when total field sensitivity depression was calculated. The permutations performed allowed us to consider different ways of quantitating the data. Again, the sickle cell patients with maculopathy who had good visual acuity but an abnormally enlarged FAZ revealed significantly large scotomas. For each calculated value the patients with maculopathy had larger defects than those without maculopathy.
The scotomas matched well the geographic distribution of non-perfusion by angiography (Figs. 2, 3) . However, the limitations of resolution in Program 33 at 60 precluded the exact superimposition of the central angiograms on the visual fields. Inasmuch as their is a learning curve associated with any psychophysical measurement and the testing situation itself is a variable process, it can be argued that a single test might not be of major importance. However, the fact that every parameter studied (that is, largest scotoma) was significantly increased in the maculopathy patients shows the data to be internally consistent, thereby supporting the value of the test.
We believe that macular ischaemia is quantifiable by the two techniques presented herein: measurement of the FAZ by angiography and assessment of the depth of threshold depression by Octopus perimetry. Since all but two of our subjects had visual acuities equal to or better than 20/30, both techniques which demonstrated anatomical and functional abnormalities appear to provide a more sensitive measurement of macular disease than visual acuity testing. 
